Parameters | Phaco-viscocanalostomy group (n = 39) | Phaco-viscocanalostomy with Ologen® implant group (n = 40) | ||||
---|---|---|---|---|---|---|
Preoperative | Postoperative | P value | Preoperative | Postoperative | P value | |
Visual acuity | ||||||
Range | 0.1–0.7 | 0.5–1.0 | 0.1–0.6 | 0.5–1.0 | ||
mean ± SD | 0.41 ± 0.18 | 0.75 ± 0.18 | < 0.001† | 0.37 ± 0.17 | 0.73 ± 0.19 | < 0.001† |
IOPa; mmHg | ||||||
Range | 15–25 | 15–22 | 14–26 | 13–21 | ||
mean ± SD | 19.46 ± 3.26 | 16.85 ± 1.58 | < 0.001† | 19.18 ± 3.19 | 15.96 ± 1.79 | < 0.001† |
Antiglaucoma drugs; n | ||||||
Range | 2–4 | 0–4 | 2–4 | 0–4 | ||
mean ± SD | 2.85 ± 0.87 | 0.64 ± 1.01 | < 0.001‡ | 2.88 ± 0.91 | 0.35 ± 0.86 | < 0.001‡ |